Impact of NCI-mandated scientific review on protocol development and content.

ABSTRACT:

Purpose

The NCI requirement that clinical trials at NCI-designated cancer centers undergo scientific review in addition to Institutional Review Board review is unique among medical specialties. We evaluated the impact of this process on protocol development and content.

Methods

We analyzed cancer clinical trials that underwent full board review by the Harold C. Simmons Cancer Center Protocol Review and Monitoring Committee (PRMC) from January 1, 2009, through June 30, 2013. We analyzed associations between trial characteristics, PRMC decisions, and protocol modifications using Chi-square testing, Fishers exact testing, and logistic regression.

Results

A total of 226 trials were analyzed. Of these, 77% were industry-sponsored and 23% were investigator-initiated. Initia

SUBMITTER: Ning N 

PROVIDER: S-EPMC5119526 | biostudies-literature | 2015 Apr

REPOSITORIES: biostudies-literature